Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ClinTrials revenues from Sandoz totaled $14.5 mil. in 1995, CRO's 2.6 mil.-share offering discloses.

Executive Summary

CLINTRIALS REVENUES FROM SANDOZ TOTALED $14.5 MIL. IN 1995, the clinical research organization reports in a June 27 public offering prospectus. Sandoz, one of three clients with whom ClinTrials has entered into strategic alliances, accounted for approximately 25% of ClinTrials' net service revenues of $57.9 mil., the prospectus states. SmithKline Beecham, another ClinTrials partner, accounted for 18% of net service revenues, or $10.4 mil. Baxter is ClinTrials' third strategic partner.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS028539

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel